SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
MRK Analysis & Videos »
MRK: Bull or Bear?
Where should granny put $50,000?
MRK
|
|
|
+13.00%
in
58 days
Filed under: Getting started, McDonald's (MCD), Diageo plc (DEO), Johnson and Johnson (JNJ), Altria Group (MO), Novartis AG ADS (NVS), Automatic Data Proc (ADP), Kellogg Co (K), Consolidated Edison (ED), General Mills (GIS), Procter and Gamble (PG), Merck and Co (MRK), Duke Energy (DUK), Personal finance, S and P 500, Stocks to Buy, Southern Company (SO), Annaly Capital Management (NLY) <> One of my wonderful friends, Ms. P, asked me for some guidance on how she might allocate $50,000 currently earning peanuts in a money market account. Though she is decades from becoming a grandmother, after a...
|
Dogs of the Dow: A look at five high yielders
MRK
+15.01%
in
79 days
Filed under: Newsletters, AT and T (T), Verizon Communications (VZ), duPont(E.I.)deNemours (DD), Merck and Co (MRK), Kraft Foods'A' (KFT), DJIA, Stocks to Buy "The Dogs of the Dow strategy has a long-term history of outperforming the Dow Jones average," notes technical expert Gerald Appel. In his Systems & Forecasts, he explains, "The theory is that the highest yielding stocks are undervalued and should have the greatest change of appreciating." Here, he reviews the 5 highest yielders. <>"In calculating a formal track record for the strategy, dividend yields are ranked on the last trading day of...
|
Bellwether stock #8: Merck (MRK)
MRK
+22.53%
in
126 days
Filed under: Earnings reports, Merck and Co (MRK), Stocks to Buy  Although earnings for Merck (NYSE: MRK) were down in the last quarter, the stock is gaining momentum.
The pharmaceutical giant reported a 3% decrease in sales to $5.9 billion from $6.05 billion in the year-earlier period. Earnings were $1.56 billion or 74 cents per share, compared with $1.77 billion or 82 cents per share in the same quarter a year ago. <>A strong dollar and lower sales for cholesterol and vaccine drugs contributed to Merck's decline this quarter. But investors were cheered by the fact that Merck reaffirmed its ann...
|
FDA Calendar Updates: Anadys, Merck, Schering-Plough
MRK
|
|
|
+22.81%
in
129 days
Below is a summary of updates to the BioMedReports.com FDA Calendar , which includes a database of 289 entries as of 7/30/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-stage clinical trial results. ...
|
FDA Calendar, Extreme Trade Updates: CXM, ELRN, SGP, Shire
MRK
|
|
|
+0.34%
in
2 days
(closed on 07/30/09)
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 284 entries as of 7/28/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-stage clinical...
|
FDA Calendar Updates: BVX, HEB, HGSI, ONXX, SGP
MRK
|
|
|
+1.32%
in
6 days
(closed on 07/28/09)
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 273 entries as of 7/22/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pendin...
|
Updated FDA, Clinical Trial Calendars: CRME, MRK, LLY, PRX
MRK
|
|
|
+11.98%
in
103 days
(closed on 07/22/09)
<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 115 entries through 4/9/09. The FDA Calendar includes the following information: company name, ticker, decision ...
|
FDA, Clinical Trial Calendar Updates: Weight Loss, Diabetes, and More
MRK
|
|
|
-3.31%
in
9 days
(closed on 04/10/09)
<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 110 entries through 4/1/09. The FDA Calendar includes the following information: company name, ticker, decision d...
|
Upcoming FDA Advisory Panel Meetings
MRK
|
|
|
-30.08%
in
23 days
(closed on 04/01/09)
A trio of diabetes drug candidates are affected by a tougher stance at the FDA for this class of drugs, which is focused on cardiovascular risks such as heart attack and stroke. Two of the drugs will be reviewed at early April FDA advisory panel meeting while a third will likely require additional clinical trials. http://www.biomedreports.com/fda-calendar.html <> In December the FDA issued a new guidance document that recommended more stringent clinical trials for diabetes drugs to better assess heart attack and stroke risks. In a change that was effective immediately,...
|
Cramer on BloggingStocks: Cramer bullish on the Dow for '09 -- Part V
MRK
+7.52%
in
199 days
(closed on 07/27/09)
Filed under: General Electric (GE), Pfizer (PFE), Wal-Mart (WMT), Exxon Mobil (XOM), AT and T (T), Target Corp. (TGT), Johnson and Johnson (JNJ), Comcast Cl'A' (CMCSA), Procter and Gamble (PG), Lowe's Cos (LOW), Verizon Communications (VZ), Merck and Co (MRK), United Technologies (UTX), DJIA, Stocks to Buy, Cramer on BloggingStocks TheStreet.com's Jim Cramer sees a stalled industrial and a winning retail play in this final portion of his 2009 predictions.
This is the...
|
Healthcare Investing Trends in 2009
MRK
|
|
|
-23.66%
in
80 days
(closed on 03/09/09)
<> Healthcare investing trends in 2009 and beyond will be affected by the new administration's plans for healthcare reform, which are summarized at the Change.gov website . A key feature of the plan is making health insurance coverage possible for all Americans using the existing network of insurers and providers. The plan relies on tax credits for small businesses and eligible individuals to help pay the cost of health insurance premiums. Also, large employers which do not offer health insurance benefits would be required to contribute ...
|
Dissecting Defensive Dividend Stocks & ETFs
MRK
|
|
|
+6.04%
in
29 days
(closed on 12/18/08)
<> 
The accompanying table includes 47 U.S.-listed companies with market caps over $10B and dividend yields over 5%, excluding all companies from the following sectors or industry groups: finance, insurance, consumer cyclical products, retailers, and basic materials in favor of healthcare, consumer staples such as tobacco, telecom services, energy, and utilities. Also, the following dividend ETFs are included in the table as a comparison:
1.) iShares Dow Jones Select Dividend (DVY)
2.) WisdomTree Dividend Top 1...
|
People Bullish on MRK
People Bearish on MRK
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Portfolio results thru 8/8/08
- Portfolio at www.updown.com - started 1/11/08
9.8% return includes dividends and commission.
Started socialpicks on 6/30. some stocks here are not in...
|
Stock update and watch list 7/29/08
- Due to difficulties understanding the socialpicks system regarding changing rating from buy to hold and thus resetting the performance, I wanted to sum...
|
More Resources
|
About Merck & Co Inc
- Answers.com
